Cytokinetics CYTK Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$829.61M-5.7% | -$784.96M-4.4% | -$751.94M-24.0% | -$606.31M+1.5% | -$615.26M-4.4% | ||
| $11.2M+10.6% | $10.13M+5.0% | $9.65M+2.9% | $9.38M-1.3% | $9.5M-0.3% | ||
| $119.13M+6.1% | $112.29M+3.9% | $108.03M+5.2% | $102.69M+2.9% | $99.78M+2.0% | ||
| -$523.85M-2.7% | -$510.01M-17.8% | -$432.93M-1.4% | -$426.92M-7.3% | -$398M-0.5% | ||
| $25.07M+1.1% | $24.81M+21.3% | $20.45M+73.3% | $11.8M+23.3% | $9.57M+145% | ||
| —— | —— | —— | —— | —— | ||
| —— | $729.46M+33.3% | $547.1M+50.0% | $364.73M+100% | $182.37M— | ||
| $10.86M+0.5% | $10.81M+0.5% | $10.76M+0.5% | $10.71M+0.5% | $10.66M+22.8% | ||
| $527.47M+0.6% | $524.46M+26.0% | $416.14M+367% | $89.1M-89.3% | $831.57M-10.6% | ||
| —— | —— | —— | —— | —— | ||
| -$548.92M-2.6% | -$534.82M-18.0% | -$453.38M-3.3% | -$438.72M-7.6% | -$407.57M-1.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cytokinetics generate?
- Cytokinetics (CYTK) generated -$523.8M in operating cash flow over the trailing twelve months.
- What is Cytokinetics's free cash flow?
- After $25.1M of capital expenditures, Cytokinetics's free cash flow was -$548.9M over the trailing twelve months, down 34.7% year over year.
- Where does Cytokinetics's cash flow data come from?
- Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
